Elite athletes are not passive patients. They are highly invested professionals whose livelihood depends on return to play, performance, and longevity. They research. They ask questions. They speak to consultants, physios, surgeons, sports doctors, and performance staff. Then they make informed decisions about their care.
What’s frustrating is when people dismiss a modality purely because they personally haven’t used it clinically. Reading a few bullet points online is not the same as:
- assessing real patients,
- understanding indications,
- integrating it into a structured rehab plan,
- monitoring tissue response,
- and seeing outcomes over weeks and months.
Nobody is saying EMTT is a miracle cure or appropriate for every case. But pretending there’s “nothing there” while athletes are demonstrably returning to play after failed conventional pathways is intellectually lazy.
This player had:
- six months out,
- failed rehab,
- failed injections,
- previous surgery,
- private hospital input,
- loss of confidence,
- inability to tolerate football loading…
…and now he’s back playing. That matters.
Good medicine and rehabilitation should stay curious, evidence-informed, and outcome-driven — not tribal.
